HC Wainwright & Co. Reiterates Buy on Cabaletta Bio, Maintains $25 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Douglas Tsao has reiterated a Buy rating on Cabaletta Bio (NASDAQ:CABA) and maintained a $25 price target on the company's stock.
November 29, 2023 | 11:14 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. analyst Douglas Tsao reaffirmed a Buy rating on Cabaletta Bio with a $25 price target, indicating a positive outlook for the stock.
The reiteration of a Buy rating and the maintenance of a $25 price target by a reputable analyst like Douglas Tsao could lead to increased investor confidence and a potential short-term positive impact on Cabaletta Bio's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100